The ENTENTE Life Sciences Investment Forum will gather 28 European early stage innovative companies active in the health sector selected, amongst 100 applicants, directly by the investors who will participate at the event on October 9th in Bruxelles. The selected companies will pitch their innovation and developments in front of a high level investor jury including the largest venture capitalists in health in Europe like Inventages Venture Capital, Wellington, or Omnes Capital, as well as very prestigious corporate investors like GSK-SROne, Novartis Venture Funds or 3M New Ventures.
Before the company review session, the managing partners of GSK-SROne, Index Ventures, Novartis Ventures Funds and Sunstone Capital will make us the favour of sharing their thoughts on the Key investments trends in biotech, as well as a presentation of the new SME instrument from the European Commission. I am thrilled to see that the main actors of the biotech entrepreneurs have engaged into our meeting and I am looking forward to this great opportunity for the European SMEs in life Sciences”.
coordinator of ENTENTE project, executive Vice President at Inserm-Transfert.